[Effect of T-activin on the production of immune interferon]. 1984

A G Chuchalin, and V A Babushkina, and V Ia Arion, and R D Aspetov, and T B Shaĭkhinova

A study was made of the effect of T-activin on the biosynthesis of immune gamma-interferon. It was shown that in 27% of patients with chronic nonspecific pulmonary diseases, production of gamma-interferon by lymphocytes was substantially reduced during exacerbation of inflammatory process in the lungs. It was discovered that T-activin was not an interferon inductor but enhanced its synthesis in patients with a low capacity of producing immune interferon even at small doses of interferon inductor. The preparation does not produce any effect on this process in normal subjects and in patients showing the normal level of gamma-interferon. Thus T-activin can be used for stimulation of interferonogenesis.

UI MeSH Term Description Entries
D007371 Interferon-gamma The major interferon produced by mitogenically or antigenically stimulated LYMPHOCYTES. It is structurally different from TYPE I INTERFERON and its major activity is immunoregulation. It has been implicated in the expression of CLASS II HISTOCOMPATIBILITY ANTIGENS in cells that do not normally produce them, leading to AUTOIMMUNE DISEASES. Interferon Type II,Interferon, Immune,gamma-Interferon,Interferon, gamma,Type II Interferon,Immune Interferon,Interferon, Type II
D007978 Levamisole An antihelminthic drug that has been tried experimentally in rheumatic disorders where it apparently restores the immune response by increasing macrophage chemotaxis and T-lymphocyte function. Paradoxically, this immune enhancement appears to be beneficial in rheumatoid arthritis where dermatitis, leukopenia, and thrombocytopenia, and nausea and vomiting have been reported as side effects. (From Smith and Reynard, Textbook of Pharmacology, 1991, p435-6) L-Tetramisole,Levotetramisole,Decaris,Dekaris,Levamisole Hydrochloride,Solaskil,Hydrochloride, Levamisole
D008173 Lung Diseases, Obstructive Any disorder marked by obstruction of conducting airways of the lung. AIRWAY OBSTRUCTION may be acute, chronic, intermittent, or persistent. Obstructive Lung Diseases,Obstructive Pulmonary Diseases,Lung Disease, Obstructive,Obstructive Lung Disease,Obstructive Pulmonary Disease,Pulmonary Disease, Obstructive,Pulmonary Diseases, Obstructive
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D010455 Peptides Members of the class of compounds composed of AMINO ACIDS joined together by peptide bonds between adjacent amino acids into linear, branched or cyclical structures. OLIGOPEPTIDES are composed of approximately 2-12 amino acids. Polypeptides are composed of approximately 13 or more amino acids. PROTEINS are considered to be larger versions of peptides that can form into complex structures such as ENZYMES and RECEPTORS. Peptide,Polypeptide,Polypeptides
D004768 Enterotoxins Substances that are toxic to the intestinal tract causing vomiting, diarrhea, etc.; most common enterotoxins are produced by bacteria. Staphylococcal Enterotoxin,Enterotoxin,Staphylococcal Enterotoxins,Enterotoxin, Staphylococcal,Enterotoxins, Staphylococcal
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000328 Adult A person having attained full growth or maturity. Adults are of 19 through 44 years of age. For a person between 19 and 24 years of age, YOUNG ADULT is available. Adults
D013268 Stimulation, Chemical The increase in a measurable parameter of a PHYSIOLOGICAL PROCESS, including cellular, microbial, and plant; immunological, cardiovascular, respiratory, reproductive, urinary, digestive, neural, musculoskeletal, ocular, and skin physiological processes; or METABOLIC PROCESS, including enzymatic and other pharmacological processes, by a drug or other chemical. Chemical Stimulation,Chemical Stimulations,Stimulations, Chemical
D013949 Thymus Extracts Extracts of the THYMUS GLAND that contain specific factors, peptides, and proteins with specific biological activities. Thymus Extract,Extract, Thymus,Extracts, Thymus

Related Publications

A G Chuchalin, and V A Babushkina, and V Ia Arion, and R D Aspetov, and T B Shaĭkhinova
January 1982, Nihon Ika Daigaku zasshi,
A G Chuchalin, and V A Babushkina, and V Ia Arion, and R D Aspetov, and T B Shaĭkhinova
January 1982, Canadian journal of comparative medicine : Revue canadienne de medecine comparee,
A G Chuchalin, and V A Babushkina, and V Ia Arion, and R D Aspetov, and T B Shaĭkhinova
January 1987, Immunopharmacology,
A G Chuchalin, and V A Babushkina, and V Ia Arion, and R D Aspetov, and T B Shaĭkhinova
July 1981, Journal of clinical immunology,
A G Chuchalin, and V A Babushkina, and V Ia Arion, and R D Aspetov, and T B Shaĭkhinova
March 1983, Antibiotiki,
A G Chuchalin, and V A Babushkina, and V Ia Arion, and R D Aspetov, and T B Shaĭkhinova
June 1982, Journal of immunology (Baltimore, Md. : 1950),
A G Chuchalin, and V A Babushkina, and V Ia Arion, and R D Aspetov, and T B Shaĭkhinova
August 1982, Journal of immunology (Baltimore, Md. : 1950),
A G Chuchalin, and V A Babushkina, and V Ia Arion, and R D Aspetov, and T B Shaĭkhinova
April 1982, The Journal of experimental medicine,
A G Chuchalin, and V A Babushkina, and V Ia Arion, and R D Aspetov, and T B Shaĭkhinova
May 1986, Biulleten' eksperimental'noi biologii i meditsiny,
A G Chuchalin, and V A Babushkina, and V Ia Arion, and R D Aspetov, and T B Shaĭkhinova
May 1966, Journal of immunology (Baltimore, Md. : 1950),
Copied contents to your clipboard!